MCMedicalCodingSoftware
J9187

J9187: Injection, etoposide, 1 mg

HCPCSActiveBETOS O1D

J9187 is a HCPCS Level II code for injection, etoposide, 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

The CMS record for J9187

Long descriptor
Injection, etoposide, 1 mg

The official wording. This is what the code means.

Short descriptor
Inj, etoposide, 1 mg

CMS's 28-character form, which is what shows up on a remittance advice.

Added
October 1, 2026

When CMS introduced the code.

BETOS
O1D

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
51: Other

Drugs.

Codes adjacent to J9187

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J9187 is not quite right, the correct code is very often within a few positions of it.

  • J9177Injection, enfortumab vedotin-ejfv, 0.25 mg
  • J9178Injection, epirubicin hcl, 2 mg
  • J9179Injection, eribulin mesylate, 0.1 mg
  • J9181Injection, etoposide, 10 mgterminated
  • J9183Gemcitabine intravesical system, 225 mg
  • J9184Injection, gemcitabine hydrochloride (avyxa), 200 mg
  • J9185Injection, fludarabine phosphate, 50 mg
  • J9186Injection, etoposide (avyxa), 1 mg
  • J9190Injection, fluorouracil, 500 mgterminated
  • J9191Injection, fluorouracil (avyxa), 10 mg
  • J9192Injection, fluorouracil, 10 mg
  • J9196Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
  • J9198Injection, gemcitabine hydrochloride, (infugem), 100 mg
  • J9199Injection, gemcitabine hydrochloride (infugem), 200 mgterminated
  • J9200Injection, floxuridine, 500 mg
  • J9201Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
HCPCS Level II2026Q4-Oct· effective October 1, 2026